News-Medical.Net on MSN
Scientists outline how future therapies could change type 1 diabetes care
Researchers writing in The Lancet review breakthroughs in type 1 diabetes treatment, from immunotherapies that delay onset to ...
In this Healio Video Perspective from Clinical Trials at the Summit, Michael A. Singer, MD, shares the results of a phase 2a trial investigating ANXV, a phosphatidylserine blocker designed to treat re ...
Intramuscular and intravenous routes of administration of antiviral monoclonal antibody therapy clear culturable SARS-CoV-2, ...
The FDA has approved Keytruda Qlex, a faster, under-the-skin cancer treatment offering convenience and flexibility. Here's what we know.
News-Medical.Net on MSN
Intravenous lactate raises pro-BDNF levels similar to high intensity workouts
Science has confirmed what sports lovers have always known from experience: exercise is good for the brain. It increases ...
After launching a multi-campus phased rollout of the predictive insulin dosing software, Philadelphia-based Temple Health’s University Hospital has reduced hypoglycemia rates two- to threefold. The ...
Prime IV Hydration & Wellness is now offering IV drip services in Cypress, officials said. Owned by Steven and Ana Bull, the new location offers IV therapy, peptide therapy and medically guided weight ...
The U.S. Food and Drug Administration has approved a subcutaneous (SC) induction regimen of Tremfya (guselkumab) for the ...
Money Talks News on MSN
Can IV Therapy Cure Hangovers, Boost Your Energy, and Supercharge Your Immune System?
For many people, especially those dealing with chronic stress or low energy, conventional health care feels reactive and slow ...
Clinical Trials Arena on MSN
Anebulo begins Phase I trial of IV cannabis antidote
Anebulo previously evaluated selonabant as an oral treatment in a Phase II clinical trial, demonstrating potential for ...
Cancer immunotherapies, anti-cancer treatments that target a patient’s own immune system, working to make it more effective, have revolutionized the | Cancer ...
The agreement includes the transfer of regulatory dossiers, manufacturing competencies and technical support to enable GE HealthCare to drive clinical development in Japan, towards potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results